The tumor exhibited an immunohistochemical profile characterized by a complete loss of INI1 (SMARCB1) expression, coupled with epithelial membrane antigen (EMA), S100, p63, and CK MNF116 positivity. Here, SMARCB1 is linked to neoplasm.